|
Glasgow - TURQUOISE-I: SAFETY AND EFFICACY OF OMBITASVIR/ABT-450/R, DASABUVIR AND RIBAVIRIN IN HCV/HIV-1 CO-INFECTED PATIENTS RECEIVING ATAZANAVIR OR RALTEGRAVIR ART REGIMENS
|
|
|
Reported by Jules Levin
HIV Drug Therapy · Glasgow, UK · 4 November 2014
Joseph J. Eron, David Wyles, Roger Trinh, Jay Lalezari, Jihad Slim, Joseph Gathe, Peter J. Ruane, Chia Wang, Richard Elion, Gary Blick, Amit Khatri, Linda Fredrick, Melannie Co, Ronald DÕAmico, Barbara Da Silva-Tillmann, Barbara McGovern, Mark S. Sulkowski
![HCV1.gif](../images/110514/110514-1/HCV1.gif)
![HCV2.gif](../images/110514/110514-1/HCV2.gif)
![HCV3.gif](../images/110514/110514-1/HCV3.gif)
![HCV4.gif](../images/110514/110514-1/HCV4.gif)
![HCV5.gif](../images/110514/110514-1/HCV5.gif)
![HCV6.gif](../images/110514/110514-1/HCV6.gif)
![HCV7.gif](../images/110514/110514-1/HCV7.gif)
![HCV8.gif](../images/110514/110514-1/HCV8.gif)
![HCV9.gif](../images/110514/110514-1/HCV9.gif)
|
|
|
|
|
|
|